Table 2.
Postoperative VTE and others complications stratified by upper-GI cancer in France between 2015 and 2017 within first postoperative year (N=8005) (The SNDS data)a.
| Characteristics | Overall (N=8005) | Esophageal and EGJ cancer (N=3429) | Gastric cancer (N=4576) |
|---|---|---|---|
| Early events (≤90 POD) | |||
| Death | 505 (6.3) | 219 (6.4) | 286 (6.3) |
| Surgical complications | |||
| Infectious | 1136 (14.2) | 515 (15.0) | 621 (13.6) |
| Obstruction | 357 (4.5) | 97 (2.8) | 260 (5.7) |
| Haemorrhageb | 350 (4.4) | 93 (2.7) | 257 (5.6) |
| VTE | 378 (4.7) | 212 (6.2) | 166 (3.6) |
| During surgical stay | 169 (44.7) | 96 (45.3) | 73 (44.0) |
| Needing readmission | 72 (19.0) | 32 (15.1) | 40 (24.1) |
| Ambulatory management | 137 (36.3) | 84 (39.6) | 53 (31.9) |
| One year eventsc | |||
| Death | 1281 (16.8) | 539 (16.8) | 742 (16.8) |
| VTE | 501 (6.6) | 248 (7.7) | 253 (5.7) |
| Needing readmission | 229 (45.7) | 97 (39.1) | 132 (52.2) |
| Ambulatory management | 272 (54.3) | 151 (60.9) | 121 (47.8) |
| Late eventd | 129 (25.8) | 62 (25.0) | 67 (26.5) |
a
Data are presented as numbers (%).
b
Including haemothorax.
c
After exlusion of patients undergoing VTE during 90 POD and with prolonged primary surgical stay (>60 POD) (N=7631; N=3206; and N=4425, respectively).
d
Occurring between 180 and 365 POD.
EGJ, esophago-gastric Junction; POD, postoperative days; SNDS, Système National des Données de Santé; VTE, venous thromboembolism.